TY - JOUR
T1 - Immunization
T2 - vital progress, unfinished agenda
AU - Piot, Peter
AU - Larson, Heidi J.
AU - O’Brien, Katherine L.
AU - N’kengasong, John
AU - Ng, Edmond
AU - Sow, Samba
AU - Kampmann, Beate
N1 - Funding Information:
Acknowledgements Vaccine research by P.P., H.J.L., B.K. and S.S. is supported by the EU’s Innovative Medicines Initiative, the Medical Research Council of UK research and Innovation, The Bill & Melinda Gates Foundation, the European Commission, PATH, the National Institute for Health Research,GSK, Pfizer, and the Wellcome Trust. This Review does not necessarily reflect the position of the World Health Organization.
Funding Information:
Competing interests P.P. is a board member of the Coalition for Epidemic Preparedness Innovation (CEPI), and the Global Health Innovative Technology Fund; H.J.L. has a grant from GSK, and is on an Advisory Board of Takeda; K.L.O. is the director of the Department of Immunization, Vaccines, and Biologicals at the World Health Organization; J.N. is Director of the African Centres for Disease Control and Prevention of the African Union, and is a Board member of CEPI. S.S. is the Director General of the Centre for Vaccine Development, Ministry of Health, Mali and a member of the WHO/SAGE Meningitis Working Group, and is an alternate Board Member of Gavi The Vaccine Alliance; B.K. is the Director of the LSHTM Vaccine Centre, and has grants from Pfizer and GSK.
Publisher Copyright:
© 2019, Springer Nature Limited.
PY - 2019/11/7
Y1 - 2019/11/7
N2 - Vaccination against infectious diseases has changed the future of the human species, saving millions of lives every year, both children and adults, and providing major benefits to society as a whole. Here we show, however, that national and sub-national coverage of vaccination varies greatly and major unmet needs persist. Although scientific progress opens exciting perspectives in terms of new vaccines, the pathway from discovery to sustainable implementation can be long and difficult, from the financing, development and licensing to programme implementation and public acceptance. Immunization is one of the best investments in health and should remain a priority for research, industry, public health and society.
AB - Vaccination against infectious diseases has changed the future of the human species, saving millions of lives every year, both children and adults, and providing major benefits to society as a whole. Here we show, however, that national and sub-national coverage of vaccination varies greatly and major unmet needs persist. Although scientific progress opens exciting perspectives in terms of new vaccines, the pathway from discovery to sustainable implementation can be long and difficult, from the financing, development and licensing to programme implementation and public acceptance. Immunization is one of the best investments in health and should remain a priority for research, industry, public health and society.
UR - http://www.scopus.com/inward/record.url?scp=85074624814&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074624814&partnerID=8YFLogxK
U2 - 10.1038/s41586-019-1656-7
DO - 10.1038/s41586-019-1656-7
M3 - Review article
C2 - 31695203
AN - SCOPUS:85074624814
SN - 0028-0836
VL - 575
SP - 119
EP - 129
JO - Nature
JF - Nature
IS - 7781
ER -